Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitroxyl (HNO) is a simple triatomic molecule exhibiting unique pharmacological properties distinct from nitric oxide. It is a short-lived intermediate in solution due to its high reactivity and instability under physiological conditions. HNO acts as an antioxidant and neuroprotective agent, showing therapeutic potential in treating heart failure and mitigating ischemia-reperfusion injury. It reacts rapidly with thiols, making thiol-containing proteins primary targets within cells.
Vasorelaxation; antioxidant activity by reacting with thiols and other reductants; neuroprotection by minimizing excitatory amino acid-induced injury.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitroxyl (HNO).